Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other Non Operating Income (2016 - 2025)

Amphastar Pharmaceuticals has reported Other Non Operating Income over the past 13 years, most recently at $515000.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at $515000.0 for Q4 2025, down 82.55% from a year ago — trailing twelve months through Dec 2025 was $23000.0 (down 99.44% YoY), and the annual figure for FY2025 was $23000.0, down 99.44%.
  • Other Non Operating Income for Q4 2025 was $515000.0 at Amphastar Pharmaceuticals, up from $231000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for AMPH hit a ceiling of $13.3 million in Q3 2021 and a floor of -$5.5 million in Q4 2023.
  • Median Other Non Operating Income over the past 5 years was $406500.0 (2024), compared with a mean of $1.2 million.
  • Biggest five-year swings in Other Non Operating Income: plummeted 262.38% in 2023 and later soared 1618.21% in 2024.
  • Amphastar Pharmaceuticals' Other Non Operating Income stood at $2.9 million in 2021, then increased by 15.58% to $3.4 million in 2022, then plummeted by 262.38% to -$5.5 million in 2023, then soared by 153.83% to $3.0 million in 2024, then crashed by 82.55% to $515000.0 in 2025.
  • The last three reported values for Other Non Operating Income were $515000.0 (Q4 2025), $231000.0 (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.